The national insurers’ financial performance in Q1 2025: Temporary reprieve or signs of stability?

Explore the national insurers' financial performance in Q1 2025, including the major moves they've made to address profitability challenges, and what we’re watching moving forward.

Jordan Peterson
Jordan Peterson
Updated Jun 5, 2025 19 min read

Over the course of the past few weeks, all of the large, publicly-traded health plans have hosted their first set of earnings calls for the year, sharing their performance from Q1 and their outlook for the remainder of 2025. We always track financial performance of this industry sub-sector—it’s an important indicator not only of the financial prospects of the health insurance industry itself, but also offers important clues as to the nature of ongoing demographic shifts, the margin outlook for providers, the real-world/cost implications of innovations from the drug pipeline, and the state of the regulatory environment. So in today’s post, we’ll look at the “Big Five” national insurers’ financial performance in Q1 2025, talk about the major moves they’ve made to address recent profitability challenges, and outline what we’re watching moving forward.

The national insurers’ financial performance in Q1 2025 appears to improve after a few challenging quarters—with a notable exception

Insurers had a (relatively) strong showing in Q1 of 2025. This comes after several consecutive quarters in which higher utilization, rising medical and drug costs, and regulatory shifts challenged payer financials. In response, insurers have spent the past year-plus shifting their focus from enrollment growth to cost management and operational efficiency.

Let’s talk.

Questions? Want to learn more about what Union can do for you? We’d love to hear from you.